申请人:——
公开号:US20040204400A1
公开(公告)日:2004-10-14
This invention features, among others, a pyrazolopyrimidine compound of formula (A):
1
A is (CH
2
)
q
—CHR
a
R
b
; each of R
1
and R
2
, independently, is hydrogen, halogen, cyano, nitro, or alkyl; or R
1
and R
2
taken together is (CH
2
)
r
; each of R
3
and R
4
, independently, is hydrogen, halogen, cyano, nitro, or alkyl; each of R
5
, R
a
, and R
b
, independently, is aryl, aralkyl, or heteroaryl, optionally substituted with halogen, cyano, nitro, alkyl, aryl, aralkyl, heteroaryl, OR, O(O)CR, C(O)R, C(O)OR, C(O)NRR′, SR, S(O)R, S(O)OR, NRR′, NR(O)CR′, NRC(O)OR′, or NRC(O)NR′R″; each of m, n, o, p, and r, independently, is 0 or 1, and q is 0, 1, or 2; in which each of R, R′, and R″, independently, is hydrogen or alkyl, provided that the sum of m, n, o, and p is 1, 2, 3, or 4.
该发明涉及一种式(A)的吡唑吡咯啉化合物:1A为(CH2)q—CHRaRb;R1和R2中的每一个独立地为氢、卤素、氰基、硝基或烷基;或者R1和R2一起为(CH2)r;R3和R4中的每一个独立地为氢、卤素、氰基、硝基或烷基;R5、Ra和Rb中的每一个独立地为芳基、芳基烷基或杂环芳基,可选择地用卤素、氰基、硝基、烷基、芳基、芳基烷基、杂环芳基、OR、O(O)CR、C(O)R、C(O)OR、C(O)NRR′、SR、S(O)R、S(O)OR、NRR′、NR(O)CR′、NRC(O)OR′或NRC(O)NR′R″取代;m、n、o、p和r中的每一个独立地为0或1,q为0、1或2;其中R、R′和R″中的每一个独立地为氢或烷基,前提是m、n、o和p的总和为1、2、3或4。